Pubblicazioni

Donor cell derived mantle cell lymphoma in a HSCT sibling donor-recipient pair: intrinsic biological clock in lymphomagenesis

2022 - LEUKEMIA & LYMPHOMA

Musiu, P.; Quattrocchi, L.; Barberi, W.; Della Starza, I.; Elia, L.; De Novi, L. A.; Petrucci, L.; De Luca, G.; Di Rocco, A.; La Rocca, U.

Impact of donor-derived CD34+infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT

2022 - BONE MARROW TRANSPLANTATION

Czerw, T; Iacobelli, S; Malpassuti, V; Koster, L; Kroger, N; Robin, M; Maertens, J; Chevallier, P; Watz, E; Poire, X; Snowden, Ja; Kuball, J; Kinsella, F; Blaise, D; Remenyi, P; Mear, Jb; Cammenga, J; Rubio, Mt; Maury, S; Daguindau, E; Finnegan, D; Hayden, P; Hernandez-Boluda, Jc; Mclornan, D; Yakoub-Agha, I

Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial

2021 - THE LANCET. HAEMATOLOGY

Ladetto, M.; Cortelazzo, S.; Ferrero, S.; Evangelista, A.; Mian, M.; Tavarozzi, R.; Zanni, M.; Cavallo, F.; Di Rocco, A.; Stefoni, V.; Pagani, C.; Re, A.; Chiappella, A.; Balzarotti, M.; Zilioli, V. R.; Gomes da Silva, M.; Arcaini, L.; Molinari, A. L.; Ballerini, F.; Ferreri, A. J. M.; Puccini, B.; Benedetti, F.; Stefani, P. M.; Narni, F.; Casaroli, I.; Stelitano, C.; Ciccone, G.; Vitolo, U.; Martelli, M.

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT

2021 - BRITISH JOURNAL OF HAEMATOLOGY

Shimoni, A; Robin, M; Iacobelli, S; Beelen, D; Mufti, Gj; Ciceri, F; Bethge, W; Volin, L; Blaise, D; Ganser, A; Luft, T; Chevallier, P; Schwerdtfeger, R; Koster, L; de Witte, T; Kroger, N; Nagler, A; Yakoub-Agha, I

IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Lawless, S; Sbianchi, G; Morris, C; Iacobelli, S; Bosman, P; Blaise, D; Remenyi, P; Byrne, Jl; Mayer, J; Apperley, J; Lund, J; Kobbe, G; Schaap, N; Isaksson, C; Lenhoff, S; Basak, G; Touzeau, C; Wilson, Kmo; Muniz, Sg; Scheid, C; Browne, P; Anagnostopoulos, A; Rambaldi, A; Jantunen, E; Kroger, N; Schonland, S; Yakoub-Agha, I; Garderet, L

Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study

2020 - AMERICAN JOURNAL OF HEMATOLOGY

Candoni, A.; Lazzarotto, D.; Ferrara, F.; Curti, A.; Lussana, F.; Papayannidis, C.; Del Principe, M. I.; Bonifacio, M.; Mosna, F.; Delia, M.; Minetto, P.; Gottardi, M.; Fracchiolla, N.; Mancini, V.; Forghieri, F.; Zappasodi, P.; Cerrano, M.; Vitale, A.; Audisio, E.; Trappolini, S.; Romani, C.; Defina, M.; Imbergamo, S.; Ciccone, N.; Santoro, L.; Cambo, B.; Iaccarino, S.; Dargenio, M.; Aprile, L.; Chiaretti, S.; Fanin, R.; Pizzolo, G.; Foa, R.

Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation

2020 - FRONTIERS IN IMMUNOLOGY

Weber, G.; Strocchio, L.; Del Bufalo, F.; Algeri, M.; Pagliara, D.; Arnone, C. M.; De Angelis, B.; Quintarelli, C.; Locatelli, F.; Merli, P.; Caruana, I.

Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP

2020 - EUROPEAN JOURNAL OF HAEMATOLOGY

Hayden, Patrick J; Iacobelli, Simona; PÃ©rez-SimÃ³n, JosÃ© Antonio; van Biezen, Anja; Minnema, Monique; Niittyvuopio, Riitta; SchÃ¶nland, Stefan; Meijer, Ellen; Blaise, Didier; Milpied, Noel; MÃ¡rquez-Malaver, Francisco J; Veelken, Joan Hendrik; Maertens, Johan; Michallet, Mauricette; Cammenga, JÃ¶rg; N'Guyen, Stephanie; Niederwieser, Dietger; Hunault-Berger, Mathilde; Bourhis, Jean Henri; Passweg, Jakob; Bermudez, Arancha; Chalandon, Yves; Yakoub-Agha, Ibrahim; Garderet, Laurent; KrÃ¶ger, Nicolaus

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA

Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, SÃ©bastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, FrÃ©dÃ©ric